Split Rock Partners

Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.

Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.

Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.

Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.

Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

TruSignal, LLC, based in St. Cloud, Minnesota, specializes in digital marketing services, focusing on people-based marketing technology for Fortune 500 brands, agencies, and publishers. As a subsidiary of TransUnion, TruSignal leverages predictive scoring and artificial intelligence to transform large data sets into actionable insights for personalized marketing. The company's TruAudience Platform integrates a deterministic identity graph, extensive third-party data, and advanced machine learning algorithms. This platform enables clients to identify and target the most relevant audiences effectively, optimize bidding strategies for digital impressions, and facilitate audience expansion and custom audience creation. By utilizing cross-channel ID matching and robust integration APIs, TruSignal aims to deliver measurable business growth through enhanced marketing initiatives.

Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.

Gravie, Inc. is a health insurance platform based in Minneapolis, Minnesota, that provides health insurance plans for individuals, families, and employers. Established in 2013, Gravie enables users to compare insurance options available through government-run marketplaces as well as directly from insurance companies. The company specializes in designing tailored benefits plans for employees, managing payments, and offering year-round support. Its services include Gravie Care, which allows individuals to shop for their benefits, and it utilizes a mobile application and website for ease of access. Gravie's innovative approach includes a defined contribution model, allowing employers to set fixed annual budgets for health benefits while providing tools for effective cost management. The platform also facilitates a better understanding of healthcare expenses through detailed price comparisons and information on co-pays, co-insurance, and applicable tax credits.

Zyga Technology, Inc. is a medical device company focused on developing and commercializing minimally invasive products for underserved conditions of the lumbar spine. The company offers the SImmetry Sacroiliac Joint Fusion System, which provides a surgical solution for sacroiliac joint fusion, addressing issues such as joint disruptions and degenerative sacroiliitis. Additionally, Zyga is working on the Glyder Facet Restoration System, an investigational device aimed at treating chronic facetogenic pain. Founded in 2008 and based in Minnetonka, Minnesota, Zyga Technology has assembled a skilled team with extensive experience in the spine industry. As of late 2017, Zyga operates as a subsidiary of RTI Surgical, Inc.

Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

Zyga Technology, Inc. is a medical device company focused on developing and commercializing minimally invasive products for underserved conditions of the lumbar spine. The company offers the SImmetry Sacroiliac Joint Fusion System, which provides a surgical solution for sacroiliac joint fusion, addressing issues such as joint disruptions and degenerative sacroiliitis. Additionally, Zyga is working on the Glyder Facet Restoration System, an investigational device aimed at treating chronic facetogenic pain. Founded in 2008 and based in Minnetonka, Minnesota, Zyga Technology has assembled a skilled team with extensive experience in the spine industry. As of late 2017, Zyga operates as a subsidiary of RTI Surgical, Inc.

Entellus Medical, doing business as Stryker ENT, is a medical device company based in Plymouth, Minnesota, specializing in innovative solutions for ear, nose, and throat (ENT) treatments. Founded in 2006, Entellus develops and commercializes minimally invasive products aimed at addressing chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. Its product lineup includes the XprESS ENT dilation system, which offers versatility for sinus and eustachian tube procedures, and the FinESS Sinus Treatment, a direct and effective method for treating chronic rhinosinusitis that minimizes invasiveness and recovery time. The company also provides a range of surgical instruments, imaging solutions, and other tools that enhance patient care while reducing discomfort and the need for general anesthesia. By collaborating with researchers and clinicians, Entellus Medical works to meet the unmet needs of physicians and patients alike, thereby improving treatment outcomes in the ENT field.

8thBridge, headquartered in Minneapolis, Minnesota, is a Social Discovery platform that assists brands in enhancing product discovery and customer understanding. Founded in 2008, the company empowers brands to leverage social media for crowd-sourced content creation and deeper engagement with consumers. By focusing on the evolving dynamics between consumers and institutions, 8thBridge provides tools that enable retailers to gain valuable insights into customer behavior and preferences. The platform aims to convert social media interactions into measurable sales growth, addressing the challenges faced by marketing and e-commerce executives in monetizing their online presence. 8thBridge has collaborated with notable brands, including Ticketmaster and Delta Air Lines, and has been recognized as one of the top private companies in the world. It was acquired by Fluid, Inc. in April 2014 and is supported by investors such as Split Rock Partners and Trident Capital.

Nuvaira, Inc. is a medical device company focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). The company has created a novel, catheter-based Lung Denervation System designed to address airway nerve hyperactivity, a common issue in patients with COPD and asthma. This minimally invasive procedure targets the parasympathetic nerves of the lungs, aiming to enhance lung function, improve exercise capacity, and elevate the quality of life for affected individuals. Founded in 2008 and headquartered in Minneapolis, Minnesota, Nuvaira was previously known as Holaira, Inc. before rebranding in June 2017.

8thBridge, headquartered in Minneapolis, Minnesota, is a Social Discovery platform that assists brands in enhancing product discovery and customer understanding. Founded in 2008, the company empowers brands to leverage social media for crowd-sourced content creation and deeper engagement with consumers. By focusing on the evolving dynamics between consumers and institutions, 8thBridge provides tools that enable retailers to gain valuable insights into customer behavior and preferences. The platform aims to convert social media interactions into measurable sales growth, addressing the challenges faced by marketing and e-commerce executives in monetizing their online presence. 8thBridge has collaborated with notable brands, including Ticketmaster and Delta Air Lines, and has been recognized as one of the top private companies in the world. It was acquired by Fluid, Inc. in April 2014 and is supported by investors such as Split Rock Partners and Trident Capital.

Entellus Medical, doing business as Stryker ENT, is a medical device company based in Plymouth, Minnesota, specializing in innovative solutions for ear, nose, and throat (ENT) treatments. Founded in 2006, Entellus develops and commercializes minimally invasive products aimed at addressing chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. Its product lineup includes the XprESS ENT dilation system, which offers versatility for sinus and eustachian tube procedures, and the FinESS Sinus Treatment, a direct and effective method for treating chronic rhinosinusitis that minimizes invasiveness and recovery time. The company also provides a range of surgical instruments, imaging solutions, and other tools that enhance patient care while reducing discomfort and the need for general anesthesia. By collaborating with researchers and clinicians, Entellus Medical works to meet the unmet needs of physicians and patients alike, thereby improving treatment outcomes in the ENT field.

Atritech is a Minneapolis-based private company founded in 2000, specializing in innovative medical technologies aimed at preventing strokes related to atrial fibrillation. The company's flagship product, the WATCHMAN Device, offers a minimally invasive solution for patients with non-valvular atrial fibrillation at risk of stroke by sealing off the left atrial appendage, thereby preventing blood clots from entering the bloodstream. The WATCHMAN Device was first implanted in Germany in 2002 and in the United States in 2003, and has since undergone extensive clinical trials to compare its efficacy against traditional long-term anticoagulation therapies. While the device is CE marked and available in several international markets, it is currently classified for investigational use only within the United States. Atritech's technology aims to enhance the quality of life for patients by providing a permanent alternative to anticoagulant medications.

Entellus Medical, doing business as Stryker ENT, is a medical device company based in Plymouth, Minnesota, specializing in innovative solutions for ear, nose, and throat (ENT) treatments. Founded in 2006, Entellus develops and commercializes minimally invasive products aimed at addressing chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. Its product lineup includes the XprESS ENT dilation system, which offers versatility for sinus and eustachian tube procedures, and the FinESS Sinus Treatment, a direct and effective method for treating chronic rhinosinusitis that minimizes invasiveness and recovery time. The company also provides a range of surgical instruments, imaging solutions, and other tools that enhance patient care while reducing discomfort and the need for general anesthesia. By collaborating with researchers and clinicians, Entellus Medical works to meet the unmet needs of physicians and patients alike, thereby improving treatment outcomes in the ENT field.

Calabrio, Inc. is a customer experience intelligence company that specializes in developing workforce optimization software solutions for call centers. Founded in 2007 and headquartered in Minneapolis, Minnesota, Calabrio offers the Calabrio ONE software suite, which integrates various modules for call recording, quality management, workforce management, analytics, and reporting. This suite is designed to enhance agent engagement and optimize performance, catering to the evolving demands of contact centers. The company serves a diverse range of industries, including healthcare, telecommunications, retail, and finance, providing services such as project management, implementation, training, and technical support. With over 4,000 clients globally, Calabrio's web-based architecture positions contact centers as key drivers of customer insight, facilitating strategic business growth through enhanced customer interactions. The company also has additional locations in Vancouver, London, Singapore, and Stockholm, and is recognized for its innovative contributions in the workforce optimization sector.

Atritech is a Minneapolis-based private company founded in 2000, specializing in innovative medical technologies aimed at preventing strokes related to atrial fibrillation. The company's flagship product, the WATCHMAN Device, offers a minimally invasive solution for patients with non-valvular atrial fibrillation at risk of stroke by sealing off the left atrial appendage, thereby preventing blood clots from entering the bloodstream. The WATCHMAN Device was first implanted in Germany in 2002 and in the United States in 2003, and has since undergone extensive clinical trials to compare its efficacy against traditional long-term anticoagulation therapies. While the device is CE marked and available in several international markets, it is currently classified for investigational use only within the United States. Atritech's technology aims to enhance the quality of life for patients by providing a permanent alternative to anticoagulant medications.

Entellus Medical, doing business as Stryker ENT, is a medical device company based in Plymouth, Minnesota, specializing in innovative solutions for ear, nose, and throat (ENT) treatments. Founded in 2006, Entellus develops and commercializes minimally invasive products aimed at addressing chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. Its product lineup includes the XprESS ENT dilation system, which offers versatility for sinus and eustachian tube procedures, and the FinESS Sinus Treatment, a direct and effective method for treating chronic rhinosinusitis that minimizes invasiveness and recovery time. The company also provides a range of surgical instruments, imaging solutions, and other tools that enhance patient care while reducing discomfort and the need for general anesthesia. By collaborating with researchers and clinicians, Entellus Medical works to meet the unmet needs of physicians and patients alike, thereby improving treatment outcomes in the ENT field.

Entellus Medical, doing business as Stryker ENT, is a medical device company based in Plymouth, Minnesota, specializing in innovative solutions for ear, nose, and throat (ENT) treatments. Founded in 2006, Entellus develops and commercializes minimally invasive products aimed at addressing chronic sinusitis, eustachian tube dysfunction, and nasal airway obstruction. Its product lineup includes the XprESS ENT dilation system, which offers versatility for sinus and eustachian tube procedures, and the FinESS Sinus Treatment, a direct and effective method for treating chronic rhinosinusitis that minimizes invasiveness and recovery time. The company also provides a range of surgical instruments, imaging solutions, and other tools that enhance patient care while reducing discomfort and the need for general anesthesia. By collaborating with researchers and clinicians, Entellus Medical works to meet the unmet needs of physicians and patients alike, thereby improving treatment outcomes in the ENT field.

Atritech is a Minneapolis-based private company founded in 2000, specializing in innovative medical technologies aimed at preventing strokes related to atrial fibrillation. The company's flagship product, the WATCHMAN Device, offers a minimally invasive solution for patients with non-valvular atrial fibrillation at risk of stroke by sealing off the left atrial appendage, thereby preventing blood clots from entering the bloodstream. The WATCHMAN Device was first implanted in Germany in 2002 and in the United States in 2003, and has since undergone extensive clinical trials to compare its efficacy against traditional long-term anticoagulation therapies. While the device is CE marked and available in several international markets, it is currently classified for investigational use only within the United States. Atritech's technology aims to enhance the quality of life for patients by providing a permanent alternative to anticoagulant medications.

Spanlink Communications, Inc. specializes in business communications technology and network integration solutions, serving clients both in the United States and internationally. The company offers a variety of packaged applications designed to enhance customer satisfaction and operational efficiency, including the Spanlink Courtesy Callback, Customer Survey Manager, Spanlink Top Customer, and SolutionWatch for monitoring network performance. Additionally, Spanlink provides CentralControl, a system management tool that facilitates multi-tenancy and voice network management, along with IVR toolkits for various contact center platforms. Their service offerings encompass analysis, design, implementation, and support, as well as consultative services such as voice readiness assessments and post-deployment evaluations. Spanlink also delivers comprehensive contact center solutions, including unified communications and business process automation. Founded in 1988 and headquartered in Minneapolis, Minnesota, Spanlink Communications integrates advanced technologies to optimize customer interactions and workforce performance within VoIP network infrastructures.